Florida Statute 465.0251 - Full Text and Legal Analysis

The 2025 Florida Statutes

Title XXXII
REGULATION OF PROFESSIONS AND OCCUPATIONS

Chapter 465
PHARMACY

View Entire Chapter

F.S. 465.0251

465.0251 Generic drugs; removal from formulary under specified circumstances.—

(1) The Board of Pharmacy and the Board of Medicine shall remove any generic named drug product from the formulary established by s. 465.025(6), if every commercially marketed equivalent of that drug product is “A” rated as therapeutically equivalent to a reference listed drug or is a reference listed drug as referred to in “Approved Drug Products with Therapeutic Equivalence Evaluations” (Orange Book) published by the United States Food and Drug Administration.

(2) Nothing in this act shall alter or amend s. 465.025 as to existing law providing for the authority of physicians to prohibit generic drug substitution by writing “medically necessary” on the prescription.

History.—ss. 1, 2, ch. 2001-146.

F.S. 465.0251 on Google Scholar

F.S. 465.0251 on CourtListener

Amendments to 465.0251

Annotations, Discussions, Cases:

Cases Citing Statute 465.0251

Total Results: 1

Abbott Laboratories v. Mylan Pharmaceuticals, Inc.

15 So. 3d 642, 2009 Fla. App. LEXIS 8512, 2009 WL 1741035

District Court of Appeal of Florida | Filed: Jun 22, 2009 | Docket: 1660783

Cited 5 times | Published

with the provisions of section 465.0251(1), Florida Statutes (2007). Section 465.0251(1) removes a generic